Antibody Drug Conjugates (ADC) for Cancer

Q: What is the mechanism of action of ADCs?

The chemical linker in the ADC process promotes the release of the payload or cytotoxic drug, which ultimately helps in cancer cell DNA damage.

Q: What are the components of ADCs?

An ADC has three primary components: a monoclonal antibody, a cytotoxic payload, and a chemical linker.

Q: Are there any negative effects of ADCs?

If the ADC is released into the blood before it reaches the cancer cells, there can be issues such as blood cell and platelet depletion.

Blog
Anti Body Drug Conjugate (ADC): Role in Managing Advanced Cancers

Frequently Asked Questions

What are ADCs in cancer treatment?

ADCs are modern-day pharmacological compounds that can treat several cancers with absolute effectiveness and targeting. Because they target only the specific cancer cells, they induce less toxicity and fewer side effects.

Frequently Asked Questions

What are ADCs in cancer treatment?

What is the mechanism of action of ADCs?

What are the components of ADCs?

What are the various ADCs?

Are there any negative effects of ADCs?